Back
Global X NASDAQ 100 Covered Call ETF Vs. Bright Minds Biosciences, Inc. Sector Stock Comparison
Buy
67
QYLD
Global X NASDAQ 100 Covered Call ETF
Last Price:
$17.76
Seasonality Move:
-2.58%
Sell
50
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$82.37
Seasonality Move:
-32.54%
Buy
67
Global X NASDAQ 100 Covered Call ETF (QYLD)
is a Buy
Is Global X NASDAQ 100 Covered Call ETF a Buy, Sell or Hold?
-
The current Global X NASDAQ 100 Covered Call ETF [QYLD] share price is $17.73. The Score for QYLD is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
QYLD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Bright Minds Biosciences, Inc. (DRUG)
is a Sell
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $84.66. The Score for DRUG is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
QYLD Stock Price Chart
What is Global X NASDAQ 100 Covered Call ETF's stock price today?
-
The Global X NASDAQ 100 Covered Call ETF share price today is $17.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QYLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $84.66The current trend is moderately bullish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
QYLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.36 | Buy |
| Relative Strength Index (14 RSI): | 66.88 | Buy |
| Chaikin Money Flow: | 1263729 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.37 - 17.63) | Buy |
| Bollinger Bands (100): | (16.82 - 17.48) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.95 | Buy |
| Relative Strength Index (14 RSI): | 59.36 | Buy |
| Chaikin Money Flow: | -90664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.18 - 85.92) | Buy |
| Bollinger Bands (100): | (42.89 - 71.15) | Buy |
QYLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.62 | Buy |
| 20-day SMA: | 17.55 | Buy |
| 50-day SMA: | 17.43 | Buy |
| 200-day SMA: | 16.83 | Buy |
| 8-day EMA: | 12.65 | Buy |
| 20-day EMA: | 6.96 | Buy |
| 50-day EMA: | 3.2 | Buy |
| 200-day EMA: | 0.86 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.31 | Sell |
| 20-day SMA: | 79.19 | Buy |
| 50-day SMA: | 67.29 | Buy |
| 200-day SMA: | 43.78 | Buy |
| 8-day EMA: | 83.88 | Buy |
| 20-day EMA: | 78.98 | Buy |
| 50-day EMA: | 69.26 | Buy |
| 200-day EMA: | 48.69 | Buy |
Global X NASDAQ 100 Covered Call ETF Earnings Growth & QYLD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
Global X NASDAQ 100 Covered Call ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||